Irvine-based upstart Spiro Medical, whose chairman is Axonics founder Raymond Cohen, raised a $67 million Series A funding round to develop a new asthma treatment ...
Spiro Medical, which debuted last year, reeled in $67 million in series A funding it plans to use to develop its novel treatment for asthma. Dubbed the Pulmonary Neuromodulation System, the platform ...
IRVINE, Calif., Jan. 7, 2026 /PRNewswire/ -- Spiro Medical, Inc., a Newco established to develop the first of its kind Pulmonary Neuromodulation System (PNM) for the treatment of Asthma announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results